p53 tumour suppressor gene polymorphism is associated with recurrent implantation failure

Reproductive BioMedicine Online

Volumn 13, Issue 4, 2006, Pages 492-496

  Kay, C ^a   Jeyendran, R S ^a   Coulam, Carolyn B ^b  

^a Andrology Laboratory Services   (United States)

^b Pregnancy Success Center of the Rinehart Center for Reproductive Medicine   (United States)

Author keywords

p53; Polymorphism; Recurrent implantation failure

Indexed keywords

ARGININE; DNA; PROLINE; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ADULT; ANGIOGENESIS; ARTICLE; CELL GROWTH; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; EMBRYO TRANSFER; ENDOMETRIUM; FEMALE; FERTILIZATION IN VITRO; FETUS CIRCULATION; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NIDATION; ORAL BIOPSY; POLYMERASE CHAIN REACTION; PREGNANCY DISORDER; RECURRENT ABORTION; RECURRENT DISEASE; RISK FACTOR; TREATMENT FAILURE; TROPHOBLAST;

EID: 33749673048     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60635-9     Document Type: Article

References (30)

1. Center for Disease Control 2002 Assisted Reproductive Technology (ART) Report: Introduction to the 2002 National Report. http://www.cdc.gov/ART/ ART02/nation.htm [accessed 12 July 2006].
2. Choi HK, Choi BC, Lee SH et al. 2003 Expression of angiogenesis-and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients. Molecular Reproduction and Development 66, 24-31.
3. Coulam CB 1995 Implantation failure and immunotherapy. Human Reproduction 10, 1338-1340.
4. Coulam CB, Jeyendran RS, Fishel LA, Roussev R 2006a Multiple thrombophilic gene mutations are risk factors for implantation failure. Reproductive BioMedicine Online 12, 322-327.
5. Coulam CB, Kay C, Jeyendran RS 2006b The role of p53 codon 72 polymorphism in recurrent pregnancy loss. Reproductive BioMedicine Online 12, 378-382.
6. Dameron KM, Volpert OV, Tainsky MA, Bouck N 1994 The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin. Cold Spring Harbor Symposium of Quantitative Biology 59, 483-489.
7. Denschlag D, Bettendorf H, Watermann D et al. 2005 Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma. Fertility and Sterility 84, 162-166.
8. Dimitriadis E, White CA, Jones RL, Salamonsen LA 2005 Cytokines and growth factors in endometrium related to implantation. Human Reproduction Update 11, 613-630.
9. Edwards RG, Beard HK 1999 Is the success of human IVF more a matter of genetics and evolution than growing blastocysts? Human Reproduction 14, 1-6.
10. Edwards RG, Brody SA 1995 Principles and Practice of Assisted Human Reproduction. WB Saunders Co, Philadelphia, USA.
11. Elder-Geva T, Meagher S, Healy DL et al. 1998 Effect of intramural, subserosal and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment. Fertility and Sterility 70, 687-691.
12. Galen A, Herrer R, Remohi J et al. 2000 Embryonic regulation of endometrial epithelial apoptosis during human implantation. Human Reproduction 15, 74-80.
13. Gianaroli L, Magli MC, Ferraretti AP et al. 2005 The beneficial effects of preimplantation genetic diagnosis for aneuploidy support extensive clinical application. Reproductive BioMedicine Online 10, 633-640.
14. Graeber TG, Osmanian C, Jacks T et al. 1996 Hypoxia-mediated selection of cells with diminished apatotic potential in solid tumours. Nature 379, 88-91.
15. Hoozemans DA, Schats R, Lambalk CB et al. 2004 Human embryo implantation: current knowledge and clinical implications in assisted reproductive technology. Reproductive BioMedicine Online 9, 692-715.
16. Huang LC, Clarkin KC, Wahl GM 1996 Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest. Proceedings of the National Academy of Sciences of the USA 93, 4827-4832.
17. Madon PF, Athalye AS, Parikh FR 2005 Polymorphic variants on chromosomes probably play a significant role in infertility. Reproductive BioMedicine Online 11, 726-732.
18. Munné S, Magli C, Cohen J, et al. 1999 Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. Human Reproduction 14, 2191-2199.
19. Munné S, Alikani M, Tomkin G et al. 1995 Embryo morphology, development rates, and maternal age are correlated with chromosome abnormalities. Fertility and Sterility 64, 382-391.
20. Pietrowski D, Bettendorf H, Riener EK et al. 2005 Recurrent pregnancy failure is associated with a polymorphism in the p53 tumour suppressor gene. Human Reproduction 20, 848-851.
21. Pim D, Banks L 2004 p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. International Journal of Cancer 108, 196-199.
22. Ravi R, Mookerjee B, Bhujwalla ZM et al. 2000 Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes and Development 14, 34-44.
23. Red-Horse K, Zhou Y, Genbacev O et al. 2004 Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. Journal of Clinical Investigation 114, 744-754.
24. Sakamuro D, Sabbatini P, White E, Prendergast GC 1997 The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15, 887-898.
25. Savion S, Lepsky E, Orenstein H, et al. 2002 Apoptosis in the uterus of mice with pregnancy loss. American Journal of Reproductive Immunology 47, 118-127.
26. Símon C, Dominguez F, Remohi J, Pellicer A 2001 Embryo effects in human implantation: embryonic regulation of endometrial molecules in human implantation. Annals of the New York Academy of Sciences 943, 1-6.
27. Smith SC, Baker PN, Symonds EM 1997 Placental apoptosis in normal human pregnancy. American Journal of Obstetrics and Gynecology 177, 57-65.
28. Smith SK 2000 Angiogenesis and implantation. Human Reproduction 15, 59-66.
29. Urman B, Yakin K, Balaban B 2005 Recurrent implantation failure in assisted reproduction: how to counsel and manage. A. General considerations and treatment options that may benefit the couple. Reproductive BioMedicine Online 11, 371-381.
30. Yuan A, Yu CJ, Luh KT et al. 2002 Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer. Journal of Clinical Oncology 20, 900-910.